[Last updated: 8th December, 2025]

This page exists to make my incentives legible and policies clear. If incentives are unclear, people should assume the worst. This is me removing that ambiguity.

Charity and sustainability

People who have already had almost everything taken away by chronic disease should not be further disadvantaged financially by engaging with my work.

In practice: I do not charge sick people for my time, and I do not run patient-facing for-profit services. There are no affiliate links, paid placements, sponsored recommendations, or covert monetisation embedded in the Born Free work.

I welcome donations and community contributions towards the Born Free project, but I do not solicit them. I do provide an optional donations link for people who ask or desire to support it.

Work is underway to establish a foundation and non-profit institute, expanding into multiple regions, to improve clinician education and accessibility. Funding is intended to come from philanthropy, donations, fundraising, clinician education and membership fees (for professionals, not patients), and speaking engagements.

No money from supplements, labs, clinics, or product ecosystems

I do not accept money, equity, referral fees, revenue share, commissions, gifts, travel, in-kind benefits, or paid ‘advisory’ roles from supplement companies, pharmaceutical companies, medical device companies, testing labs, clinics, or any business materially selling products or services to the audience this work affects.

Disclosures (including ‘none’)

I maintain a public disclosures record. If there is nothing to disclose, it will state ‘none’ with a date. If anything changes, the disclosure is updated as soon as practicable and before I publish any relevant public content.

What I do and do not offer

I publish models, hypotheses, and protocols, plus tools and education aimed at moving a neglected problem forward.

I am not offering individual clinical care. If someone is looking for diagnosis, prescriptions, or case management, I am not a substitute for that. Where I do accept consulting work, it is for organisations (for example, research, engineering, strategy, clinician education), patient advocacy and unpaid protocol navigation/education. I am contactable for clarification on any aspects of the disease modelling and protocol implementation / usage, as defined below. I provide educational support and non-prescription suggestions for you to review with your primary clinician. I do not provide diagnosis, prescriptions, or direct case management.

Conflicts of interest, sponsorship, and incentives

I avoid financial relationships that would predictably bias what I say.

If I ever do take on paid work that creates a plausible conflict with any public claims (for example, advising a company, lab, clinic, or product), I will disclose it on any relevant pages where that relationship could influence interpretation.

Product and clinician mentions, or “how to interpret recommendations”

When I mention products, labs, or clinicians, it is because they are useful examples, not because I am being paid.

I will preferentially describe what a tool does, what the decision trade-offs are, and what failure modes to watch for, rather than telling people “buy X”. If I’m forced to get specific, I’ll try to give multiple options across price and geography.

Evidence standards, or “how I label claims”

Many medical areas that matter here are literature-thin, politicised, or methodologically messy. So I separate:

“Established” – supported by multiple independent lines of evidence, consistent mechanisms, and replication.

“Probable” – reasonable synthesis, but still burdened by limited replication, selection bias, or weak endpoints.

“Speculative” – mechanistically plausible, early evidence, or working hypotheses, included because the field is stuck and needs options worth testing.

If something is speculative, I will treat and communicate that in tone and confidence.

Scientific integrity and error correction

I’m human and despite best efforts, I expect parts of my work may sometimes be wrong. The only unacceptable failure mode is refusing to correct it.

If you think I have made a factual error, misread a paper, overclaimed, or missed a major confounder, contact me. If you include sources, I will prioritise review.

Corrections will be handled by updating the relevant page and noting the correction. Science is always evolving. If a claim materially changes, I would rather be publicly corrected than quietly wrong.

Independence from ideology and tribal politics

I do not optimise for fitting into a political tribe. I optimise for reducing suffering and increasing truthfulness.

My default stance is scepticism of narratives, including narratives I like. I will criticise institutions when evidence warrants it, and I will also criticise “anti-institution” narratives when they become lazy, conspiratorial, or unfalsifiable.

Community conduct and ethics of influence

I do not support harassment, doxxing, threats, or targeting of individuals. Disagreement is normal and required to create robust outcomes, cruelty is not.

I will not use fear-based persuasion, miracle framing, or “this one weird trick” marketing. If something is risky, controversial, or uncertain, it should read that way.

Use of AI and assistance

I use modern tools, including AI, for drafting code, and synthesis. Communication should be transparent and verifiable. I aim to structure my writing so the reader can audit the reasoning and references, rather than taking ideas on trust.

Consulting and paid work boundaries

I may accept consulting work from organisations (for example, research strategy, engineering, education, communications). Other than patient advocacy and protocol navigation, I do not accept work that is direct patient-facing clinical care, nor private paid access from sick individuals seeking treatment.

If I do paid work within health-adjacent domains, it will be structured to minimise conflicts, and it will be disclosed both centrally and on relevant pages.

I do not accept money, equity, referral fees, revenue share, commissions, gifts, travel, in-kind support, or paid “advisory” roles from:

supplement companies, pharmaceutical companies, medical device companies, testing labs, clinics, or any business materially selling products or services to the audience this work affects.

(If you think a relationship fits the spirit of the above even if it avoids the letter, assume the answer is “no”.)

I do unpaid patient advocacy work aimed at improving clinician understanding, standards of care, and practical decision-making in neglected chronic disease.

In practice, this usually flows into clinician education, translating patient experience and systems-level research into teachable models, failure modes, and testable hypotheses.

This advocacy is not lobbying for commercial interests, and it is not a marketing channel for products, clinics, or tests. I do not accept money or benefits from supplement companies, clinics, or labs for advocacy or education. If I am paid by a professional or educational organisation for lectures, training, or curriculum work, that payment will be disclosed (centrally and on relevant pages), and it will not include product promotion requirements.

Participant navigation and clinician liaison (unpaid)

I frequently provide unpaid support to participants to help them navigate the Born Free protocol and connect their clinician to the most relevant parts of it.

This can include reviewing participant-provided history and test results, to highlight protocol-defined follow-ups that correspond to patterns in user-provided data. This is educational context for discussion with their clinician only and not clinical care.

I am not a registered healthcare professional. I don’t make decisions for you. I can explain what the disease model and / or protocol says and what questions to ask your clinician. I may suggest diet and non-prescription supplement options (including protocol-listed doses/forms and, where appropriate, other evidence-supported options) as discussion prompts for the participant and their clinician, I do not advise starting/stopping/changing prescription medicines, and I do not provide diagnosis or medical treatment. When I communicate with clinicians, I provide structured summaries, references, uncertainties, and questions to consider, not directives

With the participant’s explicit permission, I may contact their clinician, or respond to clinician questions. This is often how clinician education relationships form. Where feasible, I keep the participant included in clinician communications (for example CC’d on emails).

I am not a time-critical service and not an emergency contact. I may decline to engage when expectations drift toward ongoing clinical management. Where possible, I prefer to answer protocol questions publicly so that the information benefits more people.

In NSW, Australia, an unregistered health practitioner is required to abide by a code of conduct and display the relevant notice on their website or place of business, along with a Secretary-approved Notice on how to make a complaint.

Information handling, notes, and confidentiality

To stay accurate and support follow-up, I take notes and may retain relevant materials shared during communications. This information may exist across everyday tools such as email, encrypted messaging, and cloud storage. I do not accept identifiable health information via insecure channels such as Discord and will remove such content where possible. I keep consultation notes and store records securely, but this is not a hospital EMR. To view the privacy policy or request data deletion, please see Privacy Policy.

I minimise collection of sensitive data where it is not necessary for protocol navigation or clinician liaison. Identifiable participant information is treated as confidential and is not published or shared without explicit permission.

Where learnings improve public materials, they are generalised and de-identified by default.

Where publishable research efforts involve collecting data, they will be governed by explicit consent, minimal data capture, clear purpose limitation, and de-identification by default. Any/all such projects will have separate documentation covering governance, access, retention, and participant rights. Research intended for publication will seek ethics review/HREC/IRB where required.

Minors

I do not provide services directly to minors. If a parent/guardian contacts me, the engagement is with the parent/guardian only.